Positive Phase 3 Results for Novel Schizophrenia Drug ...Middle East

Medscape - News
The investigational agent xanomeline-trospium (KarXT) is safe and effective for reducing psychosis symptoms in adults with schizophrenia, topline results from the EMERGENT-2 trial suggest. Medscape Medical News

Hence then, the article about positive phase 3 results for novel schizophrenia drug was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Phase 3 Results for Novel Schizophrenia Drug )

Apple Storegoogle play

Last updated :

Also on site :